相关实验视频
Updated: Jun 14, 2025

04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.6K
肺功能对产后皮质类固醇的反应,用于预防和治疗支气管肺功能障碍症
Camilla Rigotti1, Emanuela Zannin2, Sofia Chiaraluce1
1Neonatal Intensive Care Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Pediatric research
|September 6, 2024
概括
皮质类固醇显著改善了早产婴儿的呼吸支. 结合肺超声波得分 (LUS) 和呼吸系统反应率 (Xrs),可以更好地监测治疗的有效性.
科学领域:
- 新生儿呼吸道医学 新生儿呼吸道医学
- 肺部病理学 肺部病理学
- 儿科重症监护 儿科重症监护
背景情况:
- 皮质类固醇治疗是为了改善婴儿的呼吸支持而建立的.
- 对治疗反应的客观评估对于优化护理至关重要.
研究的目的:
- 评估肺超声波得分 (LUS) 和呼吸系统反应率 (Xrs),作为对早产婴儿皮质类固醇治疗反应的客观测量.
- 为了确定是否结合LUS和Xrs可以提高治疗疗效的评估.
主要方法:
- 对早产婴儿 (<32周GA或<1500gBW) 的回顾性观察研究.
- 测量LUS和Xrs在全身德克萨梅他或吸入布德索尼德治疗前后.
- 对40名婴儿进行的46种治疗方法的分析.
主要成果:
- 所有的皮质类固醇治疗都导致呼吸支的减少.
- 在Xrs (3.13到0.44z-score,p<0.001) 和LUS (10到5,p<0.001) 两种情况下都观察到显著的改善.
- 结合LUS和Xrs提供了更全面的肺功能变化的评估.
结论:
- 呼吸系统反应率 (Xrs) 和肺超声波得分 (LUS) 是皮质类固醇诱导的肺功能变化的敏感生物标志物.
- 与单个方法相比,Xrs和LUS的组合提供了增强的评估.
- 这些发现支持在临床实践中使用呼吸系统振荡计和肺超声波的结合方法,以及对个性化皮质类固醇治疗监测的未来研究.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Pulmonary Cycle: Exhalation
1.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
246
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
246

